Ramucirumab (IMC-1121B): a novel attack on angiogenesis

By Spratlin Jennifer L   Mulder Karen E   Mackey John R  

Future Oncology, Vol. 6, Iss. 7, 2010-07 ,pp. : 1085-1094

Future Medicine

Access to resources Recommend Favorite

Protection against acute radiation-induced lung injury: A novel role for the anti-angiogenic agent Endostar

By            

Molecular Medicine Reports, Vol. 6, Iss. 2, 2012-01 ,pp. : 309-315

Spandidos Publications

Access to resources Recommend Favorite

A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 1, 2015-01 ,pp. : 37-47

Bentham Science Publishers

Access to resources Recommend Favorite

Green Tea Catechins as Novel Antitumor and Antiangiogenic Compounds

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 4, 2002-07 ,pp. : 441-463

Bentham Science Publishers

Access to resources Recommend Favorite

Norcantharidin: A potential antiangiogenic agent for gallbladder cancers in vitro and in vivo

By          

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1501-1514

Spandidos Publications

Access to resources Recommend Favorite